Hemoglobinopathies & Types: Overview, Pathophysiology, and Epidemiology
DOI:
https://doi.org/10.21839/jmhsr.2025.v8.9567Keywords:
Hemoglobinopathies, α-thalassemia, β-thalassemia, AnemiaAbstract
The hemoglobinopathies encompass all genetic diseases of hemoglobin. They fall into two main groups: thalassemia syndromes and structural hemoglobin variants (abnormal hemoglobins). α- and β-thalassemia are the main types of thalassemia; the main structural hemoglobin variants are HbS, HbE, and HbC. There are many subtypes and combined types in each group. The highly variable clinical manifestations of the hemoglobinopathies range from mild hypochromic anemia to moderate hematological disease to severe, lifelong, transfusion-dependent anemia with multiorgan involvement. According to the World Health Organization, about 5.2% of the world population and over 7% of pregnant women carry a significant variant, and 1.1% of couples worldwide are at risk of having children with a hemoglobin disorder. This review will explain the overview, pathophysiology, and epidemiologic scenarios of each hemoglobinopathy, the information of which will be useful for those who are working and interested in the following field.
Downloads
References
Aluoch, J. R. (1997). Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Tropical Medicine and International Health, 2(6), 568-571.
Arigliani, M., Kitenge, R., Castriotta, L., Ndjule, P., Barbato, V., Cogo, P., & Tshilolo, L. (2019). Lung function in children with sickle cell disease from Central Africa. Thorax, 74(6), 604-606. https://doi.org/10.1136/thoraxjnl-2018-212720
Ashurst, J., & Wasson, M. (2011). Methemoglobinemia: a systematic review of the pathophysiology, detection, and treatment. Delaware Medical Journal, 83(7), 203-208.
Burtseva, T. E., Ammosova, T. N., Protopopova, N. N., Yakovleva, S. Y., & Slobodchikova, M. P. (2017). Enzymopenic Congenital Methemoglobinemia in Children of the Republic of Sakha (Yakutia). Journal of Pediatric Hematology/Oncology, 39(1), 42-45. https://doi.org/10.1097/MPH.0000000000000705
Cappellini, M.-D., Cohen, A., Eleftheriou, A., Piga, A., Porter, J., & Taher, A. (2008). Guidelines for the Clinical Management of Thalassaemia. (2nd ed.). Nicosia, CY: Thalassaemia International Federation.
Charache, S., Conley, C. L., Waugh, D. F., Ugoretz, R. J., & Spurrell, J. R. (1967). Pathogenesis of hemolytic anemia in homozygous hemoglobin C disease. The Journal of Clinical Investigation, 46(11), 1795-811.
Chowdhury, M. H., Ghosh, S., Kabir, M. R., Mamun, M. A. A., & Islam, M. S. (2020). Effect of supplementary omega-3 fatty acids on pregnant women with complications and pregnancy outcomes: review from literature. The Journal of Maternal-Fetal & Neonatal Medicine, 35(13), 2564-2580. https://doi.org/10.1080/14767058.2020.1786522
Chowdhury, M. H., Shill, L. C., Purba, N. H., Rabbi, F. A., & Chowdhury, M. J. (2019). Adverse Effect of Micronutrient Deficiencies on Children’s Development: The Wasting Syndrome. Food & Nutrition: Current Research, 2(1), 136-147.
Curry, S. (1982). Methemoglobinemia. Annals of Emergency Medicine, 11(4), 214-221. https://doi.org/10.1016/S0196-0644(82)80502-7
David, A. N., Jinadu, M. Y., Wapmuk, A. E., Gbajabiamila, T. A., Okwuzu, J. O., Herbertson, E. C., & Ezechi, O. C. (2018). Prevalence and impact of sickle cell trait on the clinical and laboratory parameters of HIV infected children in Lagos, Nigeria. Pan African Medical Journal, 31, 113.
Farashi, S., & Harteveld, C. L. (2018). Molecular basis of α-thalassemia. Blood Cells, Molecules, and Diseases, 70, 43-53. https://doi.org/10.1016/j.bcmd.2017.09.004
Flint, J., Harding, R. M., Boyce, A. J., & Clegg, J. B. (1998). 1 The population genetics of the hemoglobinopathies. Bailliere's Clinical Hematology, 11(1), 1-51. https://doi.org/10.1016/S0950-3536(98)80069-3
Frazer, D. M., Wilkins, S. J., Darshan, D., Badrick, A. C., McLaren, G. D., & Anderson, G. J. (2012). Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression. British Journal of Haematology, 157(5), 615-626. https://doi.org/10.1111/j.1365-2141.2012.09104.x
Galanello, R., & Origa, R. (2010). Beta-thalassemia. Orphanet Journal of Rare Diseases, 5, 11. https://doi.org/10.1186/1750-1172-5-11
Galbraith, P. A., & Green, P. T. (1960). Hemoglobin C disease in an Anglo-Saxon family. The American Journal of Medicine, 28(6), 969-972.
Gallagher, P. G. (2015). Transporting down the road to dehydration. Blood, 126(26), 2775-2776. https://doi.org/10.1182/blood-2015-10-675488
Gualandro, S. F. M., Fonseca, G. H. H., Yokomizo, I. K., Gualandro, D. M., & Suganuma, L. M. Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality. British Journal of Haematology, 171(4), 631-637. https://doi.org/10.1111/bjh.13625
Harewood, J., & Azevedo, A. M. (2020). Alpha Thalassemia. Treasure Island, FL: StatPearls Publishing.
Harvey, R. A., & Ferrier, D. R. (2014). Lippincott's Illustrated Reviews: Biochemistry. Philadelphia, US: Wolters Kluwer Health.
Ismail, A., Yusuf, A. A., Kuliya-Gwarzo, A., Ahmed, S. G., Tabari, A. M., & Abubakar, S. A. (2019). Correlating transcranial arterial Doppler velocities with haematologic parameters and haemolytic indices of Nigerian children with sickle cell anaemia. Ultrasound, 27(2), 101-110. https://doi.org/10.1177/1742271X19836264
Jones, R. T., & Shih, T.-B. (1980). Hemoglobin variants with altered oxygen affinity. Hemoglobin, 4(3-4), 243-261. https://doi.org/10.3109/03630268008996208
Kane, G. C., Hoehn, S. M., Behrenbeck, T. R., & Mulvagh, S. L. (2007). Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Archives of Internal Medicine, 167(18), 1977-1982. https://doi.org/10.1001/archinte.167.18.1977
Kark, J. A., Posey, D. M., Schumacher, H. R., & Ruehle, C. J. (1987). Sickle-cell trait as a risk factor for sudden death in physical training. The New England Journal of Medicine, 317(13), 781-787. https://doi.org/10.1056/NEJM198709243171301
Karna, B., Jha, S. K., & Al Zaabi, E. (2020). Hemoglobin C Disease. Treasure Island, FL: StatPearls Publishing.
Kohne, E. (2011). Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Deutsches Ärzteblatt International, 108(31-32), 532-540. https://doi.org/10.3238/arztebl.2011.0532
Medscape. (2017). Hemoglobin C Disease. Retrieved from https://emedicine.medscape.com/article/200853-overview
Modell, B., & Darlison, M. (2008). Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization, 86(6), 480-487. https://doi.org/10.2471/blt.06.036673
Modiano, D., Luoni, G., Sirima, B. S., Simporé, J., Verra, F., Konaté, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M., D'Urbano, L., Sanou, I., Sawadogo, A., Modiano, G., & Coluzzi, M. (2001). Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature, 414(6861), 305-308. https://doi.org/10.1038/35104556
Mozzarelli, A., Hofrichter, J., & Eaton, W. A. (1987). Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science, 237(4814), 500-506. https://doi.org/10.1126/science.3603036
Nagel, R. L., Fabry, M. E., & Steinberg, M. H. (2003). The paradox of hemoglobin SC disease. Blood Reviews, 17(3), 167-178. https://doi.org/10.1016/s0268-960x(03)00003-1
National Organization for Rare Disorders. (2017). Alpha Thalassemia. Retrieved form https://rarediseases.org/rare-diseases/alpha-thalassemia/
Needs, T., Gonzalez-Mosquera, L. F., & Lynch, D. T. (2020). Beta Thalassemia. Retrieved form Treasure Island, FL: StatPearls Publishing.
Nottage, K. A., Hankins, J. S., Faughnan, L. G., James, D. M., Richardson, J., Christensen, R., Kang, G., Smeltzer, M., Cancio, M. I., Wang, W. C., & Anghelescu, D. L. (2016). Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study. Clinical Trials, 13, 409-416.
Piccin, A., Murphy, C., Eakins, E., Rondinelli, M. B., Daves, M., Vecchiato, C., Wolf, D., Mc Mahon, C., & Smith, O. P. (2019). Insight into the complex pathophysiology of sickle cell anaemia and possible treatment. European Journal of Haematology, 102(4), 319-330. https://doi.org/10.1111/ejh.13212
Piel, F. B., & Weatherall, D. J. (2014). The α-thalassemias. The New England Journal of Medicine, 371(20), 1908-1916. https://doi.org/10.1056/NEJMra1404415
Piel, F. B., Howes, R. E., Patil, A. P., Nyangiri, O. A., Gething, P. W., Bhatt, S., Williams, T. N., Weatherall, D. J., & Hay, S. I. (2013). The distribution of haemoglobin C and its prevalence in newborns in Africa. Scientific Reports, 3, 1671. https://doi.org/10.1038/srep01671
Piel, F. B., Tatem, A. J., Huang, Z., Gupta, S., Williams, T. N., & Weatherall, D. J. (2014). Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. The Lancet. Global Health, 2(2), e80-e89. https://doi.org/10.1016/S2214-109X(13)70150-5
Rees, D. C., Thein, S. L., Osei, A., Drasar, E., Tewari, S., Hannemann, A., & Gibson, J. S. (2015). The clinical significance of K-Cl cotransport activity in red cells of patients with HbSC disease. Haematologica, 100(5), 595-600. https://doi.org/10.3324/haematol.2014.120402
Sabath, D. E. (2017). Molecular Diagnosis of Thalassemias and Hemoglobinopathies: An ACLPS Critical Review. American Journal of Clinical Pathology, 148(1), 6-15. https://doi.org/10.1093/ajcp/aqx047
Saraf, S. L., Molokie, R. E., Nouraie, M., Sable, C. A., Luchtman-Jones, L., Ensing, G. J., Campbell, A. D., Rana, S. R., Niu, X. M., Machado, R. F., Gladwin, M. T., & Gordeuk, V. R. (2014). Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatric Respiratory Reviews, 15(1), 4-12. https://doi.org/10.1016/j.prrv.2013.11.003
Schneider, R. G., Hightower, B., Hosty, T. S., Ryder, H., Tomlin, G., Atkins, R., Brimhall, B., & Jones, R. T. (1976). Abnormal hemoglobins in a quarter million people. Blood, 48(5), 629-637. https://doi.org/10.1182/blood.V48.5.629.629
Skold, A., Cosco, D. L., & Klein, R. (2011). Methemoglobinemia: pathogenesis, diagnosis, and management. Southern Medical Journal, 104(11), 757-761. https://doi.org/10.1097/SMJ.0b013e318232139f
Steinberg, M. H., & Nagel, R. L. (2009). Hemoglobin SC disease and hemoglobin C disorders. In M. H. Steinberg, B. G. Forget, D. R. & D. J. Weatherall (Eds.) Disorders of hemoglobin (pp. 525-548) Cambridge, UK: Cambridge University Press
Streetly, A., Clarke, M., Downing, M., Farrar, L., Foo, Y., Hall, K., Kemp, H., Newbold, J., Walsh, P., Yates, J., & Henthorn, J. (2008). Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005. Journal of Medical Screening, 15(1), 9-13. https://doi.org/10.1258/jms.2008.007063
Teixeira, C., Pina, D., & Freitas, M. I. (2017). Automated detection of unstable hemoglobin variants by Sysmex XE-Series analyzers. Clinical Chemistry and Laboratory Medicine, 55(11), e243-e246. https://doi.org/10.1515/cclm-2017-0231
Therrell Jr, B. L., Lloyd-Puryear, M. A., Eckman, J. R., & Mann, M. Y. (2015). Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades. Seminars in Perinatology, 39(3), 238-251. https://doi.org/10.1053/j.semperi.2015.03.008
Vichinsky, E. P. (2005). Changing patterns of thalassemia worldwide. Annals of the New York Academy of Sciences, 1054, 18-24. https://doi.org/10.1196/annals.1345.003
Wang, W., Brugnara, C., Snyder, C., Wynn, L., Rogers, Z., Kalinyak, K., Brown, C., Qureshi, A., Bigelow, C., Neumayr, L., Smith-Whitley, K., Chui, D. H., Delahunty, M., Woolson, R., Steinberg, M., Telen, M., & Kesler, K. (2011). The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial. British Journal of Haematology, 152(6), 771-776. https://doi.org/10.1111/j.1365-2141.2010.08523.x
Weatherall, D. J. (2010). The inherited diseases of hemoglobin are an emerging global health burden. Blood, 115(22), 4331-4336. https://doi.org/10.1182/blood-2010-01-251348
Weatherall, D. J., & Clegg, J. B. (2001). Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, 79(8), 704-712.
Wright, R. O., Lewander, W. J., & Woolf, A. D. (1999). Methemoglobinemia: etiology, pharmacology, and clinical management. Annals of Emergency Medicine, 34(5), 646-656. https://doi.org/10.1016/s0196-0644(99)70167-8
.